img

Global Inactivated Polio and Rabies Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inactivated Polio and Rabies Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Polio vaccines can be classified into two typesthe inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.
Inactivated Polio and Rabies Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inactivated Polio and Rabies Vaccines market is projected to reach US$ 1051 million in 2029, increasing from US$ 635 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2029. Demand from Pediatrics and Adults are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inactivated Polio and Rabies Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
BIO-MED
Serum Institute of India
Kedrion Biopharma
GlaxoSmithKline
Merck
Pfizer
Segment by Type
Inactivated Polio Vaccine
Inactivated Rabies Vaccine

Segment by Application


Pediatrics
Adults

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Inactivated Polio and Rabies Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inactivated Polio and Rabies Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inactivated Polio and Rabies Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Inactivated Polio and Rabies Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inactivated Polio and Rabies Vaccines introduction, etc. Inactivated Polio and Rabies Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Inactivated Polio and Rabies Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Inactivated Polio and Rabies Vaccines Market Overview
1.1 Inactivated Polio and Rabies Vaccines Product Overview
1.2 Inactivated Polio and Rabies Vaccines Market Segment by Type
1.2.1 Inactivated Polio Vaccine
1.2.2 Inactivated Rabies Vaccine
1.3 Global Inactivated Polio and Rabies Vaccines Market Size by Type
1.3.1 Global Inactivated Polio and Rabies Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Inactivated Polio and Rabies Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Inactivated Polio and Rabies Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2018-2024)
2 Global Inactivated Polio and Rabies Vaccines Market Competition by Company
2.1 Global Top Players by Inactivated Polio and Rabies Vaccines Sales (2018-2024)
2.2 Global Top Players by Inactivated Polio and Rabies Vaccines Revenue (2018-2024)
2.3 Global Top Players by Inactivated Polio and Rabies Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Inactivated Polio and Rabies Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inactivated Polio and Rabies Vaccines Market Competitive Situation and Trends
2.5.1 Inactivated Polio and Rabies Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Inactivated Polio and Rabies Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Polio and Rabies Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Inactivated Polio and Rabies Vaccines Market
2.8 Key Manufacturers Inactivated Polio and Rabies Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inactivated Polio and Rabies Vaccines Status and Outlook by Region
3.1 Global Inactivated Polio and Rabies Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inactivated Polio and Rabies Vaccines Historic Market Size by Region
3.2.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Inactivated Polio and Rabies Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Inactivated Polio and Rabies Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Inactivated Polio and Rabies Vaccines Forecasted Market Size by Region
3.3.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Inactivated Polio and Rabies Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Inactivated Polio and Rabies Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inactivated Polio and Rabies Vaccines by Application
4.1 Inactivated Polio and Rabies Vaccines Market Segment by Application
4.1.1 Pediatrics
4.1.2 Adults
4.2 Global Inactivated Polio and Rabies Vaccines Market Size by Application
4.2.1 Global Inactivated Polio and Rabies Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Inactivated Polio and Rabies Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Inactivated Polio and Rabies Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2018-2024)
5 North America Inactivated Polio and Rabies Vaccines by Country
5.1 North America Inactivated Polio and Rabies Vaccines Historic Market Size by Country
5.1.1 North America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Inactivated Polio and Rabies Vaccines Sales in Value by Country (2018-2024)
5.2 North America Inactivated Polio and Rabies Vaccines Forecasted Market Size by Country
5.2.1 North America Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Inactivated Polio and Rabies Vaccines Sales in Value by Country (2024-2029)
6 Europe Inactivated Polio and Rabies Vaccines by Country
6.1 Europe Inactivated Polio and Rabies Vaccines Historic Market Size by Country
6.1.1 Europe Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Inactivated Polio and Rabies Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Inactivated Polio and Rabies Vaccines Forecasted Market Size by Country
6.2.1 Europe Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Inactivated Polio and Rabies Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Inactivated Polio and Rabies Vaccines by Region
7.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales in Value by Region (2024-2029)
8 Latin America Inactivated Polio and Rabies Vaccines by Country
8.1 Latin America Inactivated Polio and Rabies Vaccines Historic Market Size by Country
8.1.1 Latin America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Inactivated Polio and Rabies Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Inactivated Polio and Rabies Vaccines Forecasted Market Size by Country
8.2.1 Latin America Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inactivated Polio and Rabies Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Inactivated Polio and Rabies Vaccines by Country
9.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 BIO-MED
10.2.1 BIO-MED Company Information
10.2.2 BIO-MED Introduction and Business Overview
10.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Products Offered
10.2.5 BIO-MED Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information
10.3.2 Serum Institute of India Introduction and Business Overview
10.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Products Offered
10.3.5 Serum Institute of India Recent Development
10.4 Kedrion Biopharma
10.4.1 Kedrion Biopharma Company Information
10.4.2 Kedrion Biopharma Introduction and Business Overview
10.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Products Offered
10.4.5 Kedrion Biopharma Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Merck Inactivated Polio and Rabies Vaccines Products Offered
10.6.5 Merck Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Inactivated Polio and Rabies Vaccines Products Offered
10.7.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inactivated Polio and Rabies Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inactivated Polio and Rabies Vaccines Industrial Chain Analysis
11.4 Inactivated Polio and Rabies Vaccines Market Dynamics
11.4.1 Inactivated Polio and Rabies Vaccines Industry Trends
11.4.2 Inactivated Polio and Rabies Vaccines Market Drivers
11.4.3 Inactivated Polio and Rabies Vaccines Market Challenges
11.4.4 Inactivated Polio and Rabies Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inactivated Polio and Rabies Vaccines Distributors
12.3 Inactivated Polio and Rabies Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Inactivated Polio Vaccine
Table 2. Major Company of Inactivated Rabies Vaccine
Table 3. Global Inactivated Polio and Rabies Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 5. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Inactivated Polio and Rabies Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Inactivated Polio and Rabies Vaccines Price by Type (2018-2024) & (US$/Dose)
Table 9. Global Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 10. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Inactivated Polio and Rabies Vaccines Price by Type (2024-2029) & (US$/Dose)
Table 14. North America Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 15. North America Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2018-2024)
Table 17. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2018-2024)
Table 19. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2018-2024)
Table 21. Latin America Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2018-2024)
Table 23. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Inactivated Polio and Rabies Vaccines Sales by Company (2018-2024) & (K Dose)
Table 25. Global Inactivated Polio and Rabies Vaccines Sales Share by Company (2018-2024)
Table 26. Global Inactivated Polio and Rabies Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Inactivated Polio and Rabies Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Inactivated Polio and Rabies Vaccines Price by Company (2018-2024) & (US$/Dose)
Table 29. Global Inactivated Polio and Rabies Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Inactivated Polio and Rabies Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Polio and Rabies Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Inactivated Polio and Rabies Vaccines Market
Table 33. Key Manufacturers Inactivated Polio and Rabies Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Inactivated Polio and Rabies Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024) & (K Dose)
Table 37. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 41. Global Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 42. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2029)
Table 46. Global Inactivated Polio and Rabies Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 48. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Inactivated Polio and Rabies Vaccines Price by Application (2018-2024) & (US$/Dose)
Table 52. Global Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 53. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Inactivated Polio and Rabies Vaccines Price by Application (2024-2029) & (US$/Dose)
Table 57. North America Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) (K Dose)
Table 58. North America Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) (K Dose)
Table 60. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) (K Dose)
Table 62. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) (K Dose)
Table 64. Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) (K Dose)
Table 66. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 68. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 72. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 76. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 80. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024) & (K Dose)
Table 84. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 88. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 92. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 96. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 100. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 104. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. Bharat Biotech Company Information
Table 108. Bharat Biotech Introduction and Business Overview
Table 109. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 110. Bharat Biotech Inactivated Polio and Rabies Vaccines Product
Table 111. Bharat Biotech Recent Development
Table 112. BIO-MED Company Information
Table 113. BIO-MED Introduction and Business Overview
Table 114. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 115. BIO-MED Inactivated Polio and Rabies Vaccines Product
Table 116. BIO-MED Recent Development
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Introduction and Business Overview
Table 119. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 120. Serum Institute of India Inactivated Polio and Rabies Vaccines Product
Table 121. Serum Institute of India Recent Development
Table 122. Kedrion Biopharma Company Information
Table 123. Kedrion Biopharma Introduction and Business Overview
Table 124. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 125. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product
Table 126. Kedrion Biopharma Recent Development
Table 127. GlaxoSmithKline Company Information
Table 128. GlaxoSmithKline Introduction and Business Overview
Table 129. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 130. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product
Table 131. GlaxoSmithKline Recent Development
Table 132. Merck Company Information
Table 133. Merck Introduction and Business Overview
Table 134. Merck Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 135. Merck Inactivated Polio and Rabies Vaccines Product
Table 136. Merck Recent Development
Table 137. Pfizer Company Information
Table 138. Pfizer Introduction and Business Overview
Table 139. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 140. Pfizer Inactivated Polio and Rabies Vaccines Product
Table 141. Pfizer Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Inactivated Polio and Rabies Vaccines Market Trends
Table 145. Inactivated Polio and Rabies Vaccines Market Drivers
Table 146. Inactivated Polio and Rabies Vaccines Market Challenges
Table 147. Inactivated Polio and Rabies Vaccines Market Restraints
Table 148. Inactivated Polio and Rabies Vaccines Distributors List
Table 149. Inactivated Polio and Rabies Vaccines Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Polio and Rabies Vaccines Product Picture
Figure 2. Global Inactivated Polio and Rabies Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inactivated Polio and Rabies Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Inactivated Polio and Rabies Vaccines Sales Status and Outlook (2018-2029) & (K Dose)
Figure 5. Product Picture of Inactivated Polio Vaccine
Figure 6. Global Inactivated Polio Vaccine Sales YoY Growth (2018-2029) & (K Dose)
Figure 7. Product Picture of Inactivated Rabies Vaccine
Figure 8. Global Inactivated Rabies Vaccine Sales YoY Growth (2018-2029) & (K Dose)
Figure 9. Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Polio and Rabies Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Polio and Rabies Vaccines Revenue in 2022
Figure 23. Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Pediatrics
Figure 25. Global Pediatrics Sales YoY Growth (2018-2029) & (K Dose)
Figure 26. Product Picture of Adults
Figure 27. Global Adults Sales YoY Growth (2018-2029) & (K Dose)
Figure 28. Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application in 2022 & 2029
Figure 30. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Inactivated Polio and Rabies Vaccines Manufacturing Cost Structure
Figure 41. Inactivated Polio and Rabies Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries